AscendiantLogo Better

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Completes 21st Year in Business, Moves Forward Into Year 22

JUPITER, Florida – September 21, 2022 — Ascendiant Capital Markets LLC (“Ascendiant”) announced a milestone was reached earlier this month as September 1 marked the completion of Ascendiant’s 21st year in business. For a copy of the announcement, please click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

See other recent news

September 21, 2022
Ascendiant Completes 21st Year in Business, Moves Forward Into Year 22
September 6, 2022
Ascendiant serves as Sole M&A Advisor on Sale of Royal Dental to Brident Dental & Orthodontics
July 25, 2022
Ascendiant Initiates Research Coverage on Intrusion, Inc. (Nasdaq: INTZ)
July 18, 2022
Ascendiant Initiates Research Coverage on Guardion Health Sciences, Inc. (Nasdaq: GHSI)
July 6, 2022
Ascendiant Serves as Sole M&A Advisor on SINTX Technologies, Inc.’s (Nasdaq: SINT) Acquisition of Technology Assessment & Transfer, Inc. (TA&T)
June 27, 2022
Ascendiant Initiates Research Coverage on Blackboxstocks Inc. (Nasdaq: BLBX)
June 23, 2022
Ascendiant Capital Markets LLC serves as Sole M&A Advisor on Sale of Pinnacle Precision to The Partner Companies
June 15, 2022
Ascendiant Capital Markets LLC serves as Sole Sales Agent on $46,400,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc.’s Series D Preferred Stock (NYSE American: NILE PRD)
May 31, 2022
Ascendiant Serves as Sole Placement Agent on $6,015,000 Private Placement for Nemaura Medical, Inc. (Nasdaq: NMRD), Increases Total Amount to $36,045,000 over Three Transactions
May 11, 2022
Ascendiant Capital Markets LLC serves as Sole Placement Agent on $2,765,000 Private Placement for NextPlay Technologies, Inc. (Nasdaq: NXTP), Increases Total Amount to $20,215,000 Over Five Transactions
April 7, 2022
Ascendiant Serves as Financial Advisor on $50,000,000 Registered Direct for PAVmed Inc. (Nasdaq: PAVM)
April 4, 2022
Ascendiant Serves as Sole Sales Agent on $9,360,000 At-The-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA)